Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 643-652

  Bakshi, Vaishali P ^a   Tricklebank, Mark ^b   Neijt, Hans C ^b   Lehmann Masten, Virginia ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; ALPHA AMINO 5 (PHOSPHONOMETHYL)[1,1' BIPHENYL] 3 PROPANOIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; SDZ 220 581; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CHANNEL GATING; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; BIPHENYL COMPOUNDS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; HYPERKINESIS; MALE; MOTOR ACTIVITY; PIPERAZINES; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STARTLE REACTION;

EID: 0033026480     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bakshi VP and Geyer MA (1998) Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist, dizocilpine. J Neurosci 18:8394-8401.
2. Bakshi VP, Swerdlow NR and Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794.
3. Braff DL, Grillon C and Geyer MA(1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215.
4. Bristow LJ, Landon L, Saywell KL and Tricklebank MD (1995) The glycine/NMDA receptor antagonist, L-701,324, reverses isolation-induced deficits in prepulse inhibition in the rat. Psychopharmacology 118:230-232.
5. Choi DW (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13:171-182.
6. Flicker C and Geyer MA (1982) Behavior during hippocampal microinfusions: I. Norepinephrine and diversive exploration. Brain Res Rev 4:79-103.
7. Furuya Y and Ogura H (1997) Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition. Pharmacol Biochem Behav 57: 909-913.
8. Geyer MA (1982) Variational and probabilistic aspects of exploratory behavior in space: Four stimulant styles. Psychopharmacol Bull 18:48-51.
9. Geyer MA, Russo PV and Masten VL (1986) Multivariate assessment of locomotor behavior: Pharmacological and behavioral analyses. Pharmacol Biochem Behav 25:277-288.
10. Geyer MA, Swerdlow NR, Mansbach RS and Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485-498.
11. Gold LH and Balster RL (1993) Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline. Eur J Pharmacol 230:285-292.
12. Grant KA, Colombo G, Grant J and Rogawski MA (1996) Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists. Neuropharmacology 35:1709-1719.
13. Iversen LL and Kemp JA (1994) Non-competitive NMDA receptor antagonists as drugs, in The NMDA Receptor (Collingridge GL and Watkins JC eds) pp 469-486, Oxford University Press, New York.
14. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
15. Karper LP, Grillon C, Morissey K, Abi-Saab D, Morgan CA, Charney DS and Krystal JH (1994) The effect of ketamine on the acoustic startle response. Soc Neurosci Abstr 20:482.
16. Keith VA, Mansbach RS and Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30:557-566.
17. Kretschmer BD and Koch M (1997) Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: A behavioral and microdialysis study. Psychopharmacology 130:131-138.
18. Lehmann-Masten VD and Geyer MA (1991) Spatial and temporal patterning distinguishes the locomotor effects of dizocilpine and phencyclidine in rats. Neuropharmacology 30:629-636.
19. Lowe DA, Emre M, Frey P, Kelly PH, Malanowski J, McAllister KH, Neijt HC, Rudeberg C, Urwyler S, White TG and Herling PL (1994) The pharmacology of SDZ EAA 494, a competitive NMDA receptor antagonist. Neurochem Int 25:583-600.
20. Mansbach RS (1991) Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol 202:61-66.
21. Mansbach RS and Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308.
22. Mansbach RS and Geyer MA (1991) Parametric determinants in pre-stimulus modification of acoustic startle: Interaction with ketamine. Psychopharmacology 105: 162-168.
23. Mansbach RS, Geyer MA and Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514.
24. McCloskey TC, Padich RA, Taylor VL, Schmidt CJ and Kehne JH (1995) Behavioral and neurochemical assessment of the psychotomimetic potential of the competitive NMDA receptor antagonist MDL 100,453. Soc Neurosci Abstr 21:1115.
25. McCulloch J, Bullock R and Teasdale GM (1992) Stroke and other causes of the ischaemic brain damage in man, in Excitatory Amino Acid Antagonists (Meldrum BS ed) pp 287-326, Blackwell Scientific, Oxford.
26. Meldrum BS (1988) What are the future prospects for agents decreasing excitatory neurotransmission as anti-epileptic agents? in Frontiers in Excitatory Acid Research (Calvalheiro EA, Lehmann J and Turski L eds) pp 195-202, Alan R. Liss, New York.
27. Monyer H, Sprengel R, Schopfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sackman B and Seeburg P (1992) Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science (Wash DC) 256:1217-1221.
28. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N and Nakanishi S (1991) Molecular cloning and characterisation of the rat NMDA receptor. Nature (London) 354:31-37.
29. Paulus M and Geyer MA (1991) A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology 104:6-16.
30. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Australia.
31. Reijmers LGJE, Vanderheyden PML and Peeters BWMM (1995) Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens. Eur J Pharmacol 272:131-138.
32. Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14:325-331.
33. Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D and Duncan JS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165-174.
34. Swerdlow NR, Bakshi VP and Geyer MA (1996) Seroquel restores sensorimotor gating in phencyclidine (PCP)-treated rats. J Pharmacol Exp Ther 279:1290-1299.
35. Tricklebank MD, Singh L, Oles RJ, Wong EHF and Iversen SD (1987) A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine. Eur J Pharmacol 141:497-501.
36. Tricklebank MD, Singh L, Oles RJ, Preston C and Iversen SD (1989) The behavioural effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167:127-135.
37. Urwyler S, Laurie D, Lowe DA, Meier CL and Muller W (1996a) Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists. I. Pharmacological characterization in vitro. Neuropharmacology 35:643-654.
38. Urwyler S, Campbell E, Fricker G, Jenner P, Lemaire M, McAllister KH, Neijt HC, Park CK, Perkins M, Rudin M, Sauter A, Smith L, Wiederhold KH and Muller W (1996b) Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists. II. Pharmacological characterization in vivo. Neuropharmacology 35:655-669.
39. Wan FJ and Swerdlow NR (1997) The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience 76:715-724.
40. Watkins JC (1994) The NMDA receptor concept: Origins and development, in The NMDA Receptor (Collingridge GL and Watkins JC eds) pp 1-30, Oxford University Press, New York.
41. Wedzony K, Golembiowska K and Zazula M (1994) Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA receptor antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn-Schmiedeberg's Arch Pharmakol 350:555-562.
42. Wiley JL and Balster RL (1994) Effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle. Psychopharmacology 116:266-272.